SCHEMBL11171833

SCHEMBL11171833

COc1c(CO)c2c(c(Sc3ccccc3)c1OC)CCN(C)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SMN1; SMN2 Q16637 5/20 0.37
▸ CHRNA7 P36544 1/20 0.35
▸ DRD2 P14416 4/20 0.34
▸ DRD1 P21728 2/20 0.34
▸ DRD5 P21918 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HTR1A P08908 2/20 0.33
▸ DRD4 P21917 2/20 0.33
▸ NPY1R P25929 1/20 0.33
▸ NPY2R P49146 1/20 0.33
▸ PABPC1 P11940 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11158084 0.88 DRD2 (0.37) KDM4ESMN1; SMN2CHRNA7DRD2DRD1
SCHEMBL11160741 0.83 SMN1; SMN2 (0.38) KDM4ESMN1; SMN2CHRNA7DRD2DRD1
SCHEMBL11152828 0.81 DRD2 (0.47) SMN1; SMN2CHRNA7DRD2DRD1DRD5
SCHEMBL11168165 0.81 SMN1; SMN2 (0.36) KDM4ESMN1; SMN2CHRNA7DRD2DRD1
Hydrochloric Acid SCHEMBL11193597 0.80 SMN1; SMN2 (0.39) KDM4ESMN1; SMN2CHRNA7DRD2DRD1
SCHEMBL11160867 0.78 DRD1 (0.43) DRD2DRD1DRD5DRD3HTR1A
SCHEMBL11162390 0.78 KDM4E (0.38) KDM4EALDH1A1CYP3A4HPGDMAPK1
SCHEMBL11160737 0.77 DRD1 (0.43) KDM4EMAPK1HSD17B10SMN1; SMN2DRD2
SCHEMBL11155684 0.76 DRD2 (0.41) KDM4EALDH1A1SMN1; SMN2DRD2DRD1
SCHEMBL11160967 0.75 DRD1 (0.47) CYP3A4TDP1CHRNA7DRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback